TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,223,427 | -93.1% | 146,343 | -79.6% | 0.00% | -94.9% |
| Q2 2023 | $17,809,386 | +233.3% | 716,964 | +101.8% | 0.04% | +200.0% |
| Q1 2023 | $5,342,930 | +8517.6% | 355,248 | +3283.6% | 0.01% | – |
| Q3 2022 | $62,000 | -98.9% | 10,499 | -98.2% | 0.00% | -100.0% |
| Q1 2022 | $5,531,000 | +9.4% | 581,587 | +118.5% | 0.02% | 0.0% |
| Q4 2021 | $5,057,000 | +1898.8% | 266,176 | +935.4% | 0.02% | +466.7% |
| Q1 2020 | $253,000 | -55.9% | 25,707 | -74.9% | 0.00% | 0.0% |
| Q3 2018 | $574,000 | -16.2% | 102,571 | +97.0% | 0.00% | 0.0% |
| Q2 2018 | $685,000 | – | 52,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |